Table 1.
Baseline characteristics of patient populations from TIMI Score development set and study set.
Table 2.
TIMI risk score, characteristics and risk of 30-day mortality.
Figure 1.
Percentage at risk by the TIMI risk score for the TIMI risk score development population, Malaysian STEMI population, as well as diabetic (DM) and renal impairment sub-groups.
Figure 2.
Mortality rate at 30 days for the TIMI risk score development, Malaysian STEMI population, as well as diabetic (DM) and renal impairment sub-groups.